SEC Comment Letter for BIOCRYST PHARMACEUTICALS INC (BCRX) (CIK 0000882796) (BCRX) — Feb 15, 2007

BIOCRYST PHARMACEUTICALS INC (BCRX) (CIK 0000882796)
Date: Feb. 15, 2007 · CIK: 0000882796 · Accession: 0000000000-07-008031

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-23186

Date

February 15, 2007

Author

Jim Atkinson

Form

UPLOAD

Company

BIOCRYST PHARMACEUTICALS INC (BCRX) (CIK 0000882796)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 February 15, 2007 Mr. Charles E. Bugg, Ph.D. Chairman and Chief Executive Officer BioCryst Pharmaceuticals, Inc. 2190 Parkway Lake Drive Birmingham, AL 35244

Re: BioCryst Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended December 31, 2005 Filed March 9, 2006 File No. 000-23186

Dear Mr. Bugg:

We have completed our review of your Form 10-K and have no further comment at this time.

S i n c e r e l y ,

Jim Atkinson Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 6010

                                                                                                February 15, 2007

Mr. Charles E. Bugg, Ph.D.
Chairman and Chief Executive Officer
BioCryst Pharmaceuticals, Inc.
2190 Parkway Lake Drive
Birmingham, AL  35244

Re: BioCryst Pharmaceuticals, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2005
Filed March 9, 2006
 File No. 000-23186

Dear Mr. Bugg:

 We have completed our review of your  Form 10-K and have no further comment
at this time.

        S i n c e r e l y ,

Jim Atkinson
Accounting Branch Chief

SecProbe.io